RFK Jr. is gutting minority health offices across HHS that are key to reducing health disparities

RFK Jr. is gutting minority health offices across HHS that are key to reducing health disparities

Employees of the Department of Health and Human Services (HHS) stand outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration fired staff at the Centers for Disease Control and Prevention and at the Food and Drug Administration, as it embarked on its plan to cut 10,000 jobs at HHS, … Read more

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024.  Andrew Kelly | Reuters Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and … Read more

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%

The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Tuesday said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and … Read more

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025.  Clodagh Kilcoyne | Reuters Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company’s sales fell, largely due to dwindling revenue for its antiviral Covid pill Paxlovid. The company previously … Read more

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025.  Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk scored a huge legal victory that … Read more

Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise

Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise

Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations … Read more

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday beat first-quarter estimates and hiked its revenue and profit guidance for the year, as the drugmaker cuts costs. The company now expects 2025 … Read more

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck lowers profit outlook, partly due to 0 million expected tariff hit

Nurphoto | Nurphoto | Getty Images Merck on Thursday lowered its full-year profit guidance, citing $200 million in estimated costs for tariffs and a charge tied to a recent deal. The company now expects its 2025 adjusted earnings to come in between $8.82 and $8.97, down slightly from a previous outlook of 8.88 to $9.03 … Read more

FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks

FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks

Candy is displayed for sale, as U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., along with FDA Commissioner Marty Makary, announce the FDA’s intent to remove from the U.S. food supply “petroleum-based synthetic” food dyes, which are present in numerous foods such as breakfast cereals, candy, snacks, and beverages, at a grocery … Read more

Eli Lilly shares surge on new obesity pill data. What it means for the stock from here

Eli Lilly shares surge on new obesity pill data. What it means for the stock from here

Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to broaden the appeal of its breakthrough drugs. The news Club name Lilly said its daily obesity pill was successful in a late-stage trial for Type 2 diabetes — sending shares soaring more … Read more